Feasibility and impact of prospective DPYD screening in the Irish population
Annals of Oncology(2019)
Abstract
Background Genetic variants of dihydropyrimidine dehydrogenase (DPYD) gene can result in varied enzymatic activity and potential toxicity when receiving 5-FU chemotherapy including treatment related death in up to 1% patients. Current international guidelines suggest an international rate of 3-5% albeit routine prospective pharmacogenomic testing is not currently recommended. However, in a genetically homogenous population such as Ireland, DPYD variant enrichment may support routine testing. Methods All patients receiving 5-FU based chemotherapy in South & South-West region of Ireland were prospectively tested from 01/09/2018 to present. The Viapath DPYD genotyping panel which interrogates for 5 variants was used. Toxicity type and grade for all patients were recorded (CTCAE v5.0). Results To date, 139 patients have been tested,50.4% male and 49.6% female, median age 63 years. The majority(59%) were being treated for colorectal cancer. Sixteen patients were found to be heterozygous carriers of a DYPD variant with one compound heterozygous variant identified i.e. an overall prevalence of 12 %. No homozygous carriers were identified. Grade ≥3 was observed in 33% DPYD variant carriers compared to 19% in DPYD wild type patients i.e. relative risk of grade ≥3 toxicity is 1.7, p = 0.17. Table . 648P DPYD Variants Prevalence % n = 139 % Rate of ≥ G3 toxicity 7(5.0%) 42% c. 2846A>T 1(0.7%) n/a* c. 1905 + 1G>A 3(2.2%) 100% c. 1679T>G 0 (0%) n/a* c. 1601GA 5 (3.6%) 0% c. 1905 + 1G>A+c;1236G>A/Hapb3 compound heterozygous 1(0.7%) n/a* TOTAL:17 (12.2%) Conclusions The study shows a higher than expected prevalence of DPYD variants of 12.2% compared to internationally reported 3-5%. Patients with DPYD variants c.1236G>A and c.1905+1G>A were particularly likely to develop Grade ≥ 3 toxicity. Prospective testing continues to assess the clinical relevance of individual variants in our population. Legal entity responsible for the study: The authors. Funding Has not received any funding. Disclosure All authors have declared no conflicts of interest.
MoreTranslated text
Key words
prospective dpyd screening,irish population
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined